| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Case of Pulmonary Arterial Hypertension Associated with Adult Hemophagocytic Lymphohistiocytosis
|
Koifman, Julius
|
|
2016
|
6 |
4 |
p. 614-615
|
article
|
| 2 |
An Advanced Protocol-Driven Transition from Parenteral Prostanoids to Inhaled Trepostinil in Pulmonary Arterial Hypertension
|
Oudiz, Ronald
|
|
2016
|
6 |
4 |
p. 532-538
|
article
|
| 3 |
A New Look at Bronchopulmonary Dysplasia: Postcapillary Pathophysiology and Cardiac Dysfunction
|
Sehgal, Arvind
|
|
2016
|
6 |
4 |
p. 508-515
|
article
|
| 4 |
An International Physician Survey of Chronic Thromboembolic Pulmonary Hypertension Management
|
Gall, Henning
|
|
2016
|
6 |
4 |
p. 472-482
|
article
|
| 5 |
BK Channels in Rat and Human Pulmonary Smooth Muscle Cells are BKα-β1 Functional Complexes Lacking the Oxygen-Sensitive Stress Axis Regulated Exon Insert
|
Detweiler, Neil D.
|
|
2016
|
6 |
4 |
p. 563-575
|
article
|
| 6 |
Bridging the Science into Practice
|
Preston, Ioana R.
|
|
2016
|
6 |
4 |
p. 620
|
article
|
| 7 |
Editorial Board
|
|
|
2016
|
6 |
4 |
p. i
|
article
|
| 8 |
Endotoxin- and Mechanical Stress–Induced Epigenetic Changes in the Regulation of the Nicotinamide Phosphoribosyltransferase Promoter
|
Elangovan, Venkateswaran Ramamoorthi
|
|
2016
|
6 |
4 |
p. 539-544
|
article
|
| 9 |
Erratum
|
|
|
2016
|
6 |
4 |
p. 621
|
article
|
| 10 |
Erratum
|
|
|
2016
|
6 |
4 |
p. 622
|
article
|
| 11 |
Exhaled Nitric Oxide in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
|
Cao, Zeling
|
|
2016
|
6 |
4 |
p. 545-550
|
article
|
| 12 |
Expression Profiling Elucidates a Molecular Gene Signature for Pulmonary Hypertension in Sarcoidosis
|
Singla, Sunit
|
|
2016
|
6 |
4 |
p. 465-471
|
article
|
| 13 |
Genotype-Phenotype Effects of Bmpr2 Mutations on Disease Severity in Mouse Models of Pulmonary Hypertension
|
Frump, Andrea L.
|
|
2016
|
6 |
4 |
p. 597-607
|
article
|
| 14 |
Hemodynamic Response to Treatment of Iron Deficiency Anemia in Pulmonary Arterial Hypertension: Longitudinal Insights from an Implantable Hemodynamic Monitor
|
Mehmood, Muddassir
|
|
2016
|
6 |
4 |
p. 616-618
|
article
|
| 15 |
In Situ Expression of Bcl-2 in Pulmonary Artery Endothelial Cells Associates with Pulmonary Arterial Hypertension Relative to Heart Failure with Preserved Ejection Fraction
|
Benza, Raymond L.
|
|
2016
|
6 |
4 |
p. 551-556
|
article
|
| 16 |
Macrophage Migration Inhibitory Factor as a Novel Biomarker of Portopulmonary Hypertension
|
DuBrock, Hilary M.
|
|
2016
|
6 |
4 |
p. 498-507
|
article
|
| 17 |
Novel Methods in Pulmonary Hypertension Phenotyping in the Age of Precision Medicine (2015 Grover Conference Series)
|
Barnes, Jarrod W.
|
|
2016
|
6 |
4 |
p. 439-447
|
article
|
| 18 |
Our Readership Grows by Leaps and Bounds
|
Yuan, Jason X. J.
|
|
2016
|
6 |
4 |
p. 405-406
|
article
|
| 19 |
Pulmonary Pulse Wave Transit Time is Associated with Right Ventricular–Pulmonary Artery Coupling in Pulmonary Arterial Hypertension
|
Prins, Kurt W.
|
|
2016
|
6 |
4 |
p. 576-585
|
article
|
| 20 |
Pulmonary Vascular and Ventricular Dysfunction in the Susceptible Patient (2015 Grover Conference Series)
|
Maron, Bradley A.
|
|
2016
|
6 |
4 |
p. 426-438
|
article
|
| 21 |
Relevance of Angiopoietin-2 and Soluble P-Selectin Levels in Patients with Pulmonary Arterial Hypertension Receiving Combination Therapy with Oral Treprostinil: A FREEDOM-C2 Biomarker Substudy
|
Richter, Manuel J.
|
|
2016
|
6 |
4 |
p. 516-523
|
article
|
| 22 |
Resolution of Myelofibrosis-Associated Pulmonary Arterial Hypertension following Allogeneic Hematopoietic Stem Cell Transplantation
|
Faiz, Saadia A.
|
|
2016
|
6 |
4 |
p. 611-613
|
article
|
| 23 |
Shared Gene Expression Patterns in Mesenchymal Progenitors Derived from Lung and Epidermis in Pulmonary Arterial Hypertension: Identifying Key Pathways in Pulmonary Vascular Disease
|
Gaskill, Christa
|
|
2016
|
6 |
4 |
p. 483-497
|
article
|
| 24 |
Tadalafil Therapy for Sarcoidosis-Associated Pulmonary Hypertension
|
Ford, H. J.
|
|
2016
|
6 |
4 |
p. 557-562
|
article
|
| 25 |
The Effects of Pulmonary Vasodilating Agents on Right Ventricular Parameters in Severe Group 3 Pulmonary Hypertension: A Pilot Study
|
Sato, Takahiro
|
|
2016
|
6 |
4 |
p. 524-531
|
article
|
| 26 |
The Prognostic Significance of Pulmonary Arterial Capacitance in Pulmonary Arterial Hypertension: Single-Center Experience
|
Al-Naamani, Nadine
|
|
2016
|
6 |
4 |
p. 608-610
|
article
|
| 27 |
Three-Dimensional Micro Computed Tomography Analysis of the Lung Vasculature and Differential Adipose Proteomics in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension
|
Shields, Kelly J.
|
|
2016
|
6 |
4 |
p. 586-596
|
article
|
| 28 |
Transcription Factors, Transcriptional Coregulators, and Epigenetic Modulation in the Control of Pulmonary Vascular Cell Phenotype: Therapeutic Implications for Pulmonary Hypertension (2015 Grover Conference Series)
|
Pullamsetti, Soni S.
|
|
2016
|
6 |
4 |
p. 448-464
|
article
|
| 29 |
Treatment Differences in Pulmonary Arterial Hypertension Management
|
Maron, Bradley A.
|
|
2016
|
6 |
4 |
p. 619
|
article
|
| 30 |
Unique Aspects of the Developing Lung Circulation: Structural Development and Regulation of Vasomotor Tone
|
Gao, Yuangsheng
|
|
2016
|
6 |
4 |
p. 407-425
|
article
|
Journal description